BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Park JY, Sunga O, Wanitphakdeedecha R, Frevert J. Neurotoxin Impurities: A Review of Threats to Efficacy. Plast Reconstr Surg Glob Open 2020;8:e2627. [PMID: 32095419 DOI: 10.1097/GOX.0000000000002627] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Rubis A, Juodzbalys G. The Use of Botulinum Toxin A in the Management of Trigeminal Neuralgia: a Systematic Literature Review. J Oral Maxillofac Res 2020;11:e2. [PMID: 32760475 DOI: 10.5037/jomr.2020.11202] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Carr WW, Jain N, Sublett JW. Immunogenicity of Botulinum Toxin Formulations: Potential Therapeutic Implications. Adv Ther 2021;38:5046-64. [PMID: 34515975 DOI: 10.1007/s12325-021-01882-9] [Reference Citation Analysis]
3 Kim J, Kwak S, Park MS, Rhee CH, Yang GH, Lee J, Son WC, Kang WH. Safety verification for polysorbate 20, pharmaceutical excipient for intramuscular administration, in Sprague-Dawley rats and New Zealand White rabbits. PLoS One 2021;16:e0256869. [PMID: 34449810 DOI: 10.1371/journal.pone.0256869] [Reference Citation Analysis]
4 Patil A, Kassir M, Wollina U, Goldust M. [New botulinum toxins for aesthetic dermatology : A comprehensive review]. Hautarzt 2021;72:393-402. [PMID: 33822278 DOI: 10.1007/s00105-021-04801-9] [Reference Citation Analysis]